Detection of HER2 amplification in breast carcinomas: Comparison of Multiplex Ligation-dependent Probe Amplification (MLPA) and Fluorescence In Situ Hybridization (FISH) combined with automated spot counting

Cellular Oncology

Volumn 28, Issue 4, 2006, Pages 151-159

  Moerland, Elna ^a   Van Hezik, Rens L H P M ^a   Van Der Aa, Toine C J M ^a   Van Beek, Mike W P M ^a   Van Den Brule, Adriaan J C ^a  

^a Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

Author keywords

Amplification; Automatic; FISH; HER2; MLPA; Quantification; Spot counting

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; AUTOANALYSIS; BREAST CARCINOMA; CANCER TISSUE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIGATION DEPENDENT PROBE AMPLIFICATION; MOLECULAR IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; REPRODUCIBILITY; SCORING SYSTEM;

BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33748917963     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. M. Bilous, M. Dowsett, W. Hanna, J. Isola, A. Lebeau, A. Moreno, F. Penault-Llorca, J. Ruschoff, G. Tomasic and M. Vijver, Current perspectives on HER2 testing: a review of national testing guidelines, Mod. Pathol. 16 (2002), 173-182.
2. M.C. Van Dijk, P.D. Rombout, S.H. Boots-Sprenger, H. Straatman, M.R. Bernsen, D.J. Ruiter and J.W. Jeuken, Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin fixed tissue, Diagn. Mol. Pathol. 14 (2005), 9-16.
3. A. Di Leo, M. Dowsett, B. Horten and F. Penault-Llorca, Current status of HER2 testing, Oncology 63 (2002), 25-32.
4. C.M. Ellis, M.J. Dyson, T.J. Stephenson and E.L. Maltby, HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques, J. Clin. Pathol. 58 (2005), 710-714.
5. L.M. Gjerdrum, B.S. Sorensen, E. Kjeldson, F.B. Sorensen, E. Nexo and S. Hamilton-Dutoit, Real-time quantitative PCR of Microdissected paraffin-embedded breast carcinoma, J. Mol. Diagn. 6 (2004), 42-51.
6. L. Hammock, M. Lewis, C. Philips and C. Cohen, Strong HER2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization, Hum. Pathol. 34 (2003), 1043-1047.
7. D.G. Hicks and R.R. Tubbs, Asessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines, Hum. Pathol. 36 (2005), 250-261.
8. F.B.L. Hogervorst, P.M. Nederlof, J.J.P. Gille, C.J. McElgunn, M. Grippeling, R. Pruntel, R. Regneras, T. van Welsum, R. van Spaendonk, F.H. Menko, I. Kluijt, C. Dommering, S. Verhoef, J.P. Schouten, L. van 't Veer and G. Pals, Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method, Cancer Res. 63 (2003), 1449-1453.
9. C.Y. Hsu, D.M.T. Ho, C.F. Yang, C.R. Lai, I.T. Yu and H. Chiang, Interobserver reproducibility of Her-2/neu protein overexpression in invasive breast carcinoma using the DAKO herceptest, Am. J. Clin. Pathol. 118 (2002), 693-698.
10. M. Kobayashi, A. Ooi, Y. Oda and I. Nakanishi, Protein overexpression and gene amplification of c-erb-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed praffin embedded tissues, Hum. Pathol. 33 (2002), 21-28.
11. G.E. Konecny, C. Thomssen, H.J. Luck, M. Untch, H.J. Wang, W. Kuhn, H. Eidtmann, A. du Bois, S. Olbricht, D. Steinfeldt, V. Mobus, G. von Minckwitz, S. Dandekar, L. Ramos, G. Pauletti, M.D. Pegram, F. Janicke and D.J. Slamon. HER-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer, J. Nat. Canc. Inst. 96 (2004), 1141-1151.
12. P. Lal, P.A. Salazar, M. Ladanyi and B. Chen, Impact of polysomy 17 on HER2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification, J. Mol. Diagn. 5 (2003), 155-159.
13. A. Lebeau, D. Deimling, C. Kaltz, A. Sendelhofert, A. Iff, B. Luthardt, M. Untch and U. Löhrs, HER-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization, J. Clin. Oncol. 19 (2001), 354-363.
14. S. Merkelbach-Bruse, E. Wardelmann, P. Behrens, I. Losen, R. Buettner and N. Friedrichs, Current diagnostic methods of HER-2/neu detection in breast cancer with special regard to real-time PCR, Am. J. Surg. Pathol. 27 (2003), 1565-1570.
15. A. Millson, A. Suli, L. Hartung, S. Kunitake, A. Bennett, M.C. Lowry Nordberg, W. Hanna, C.T. Wittwer, A. Seth and E. Lyon, Comparison of two quantitative polymeras chain reaction methods for detecting HER2/neu amplification, J. Mol. Diagn. 5 (2003), 184-190.
16. R. Narath, T. Lorch, M. Rudas and P.F. Ambros, Automatic quantification of gene amplification in clinical samples by IQ-FISH, Cytometry B. Clin. Cytom. 57 (2004), 15-22.
17. G. Pauletti, S. Dandekar, H. Rong, L. Ramos, H. Peng, R. Seshadri and D.J. Slamon, Assesment of methods for tissue-based detection of the HER-2neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry, J. Clin. Oncol. 18 (2000), 3651-3664.
18. M.F. Press, D.J. Slamon, K.J. Flom, J. Park, J.Y. Zhou and L. Bernstein, Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens, J. Clin. Oncol. 20 (2002), 3095-3105.
19. R.L. Ridolfi, M.R. Jamehdor and J.M. Arber, HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach, Mod. Pathol. 13 (2000), 866-873.
20. J.S. Ross and J.A. Fletcher, HER-2/neu (c-erb-B2) Gene and Protein in Breast Cancer, Am. J. Clin. Pathol. 112 (1999), S53-S67.
21. J.P. Schouten, C.J. McElgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens and G. Pals, Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acid Res. 30 (12) (2002), e57:1-13.
22. L. Sellner and G.R. Taylor, MLPA and MAPH: new techniques for detection of gene deletions, Hum. Mut. 23 (2004), 413-419.
23. H.R. Slater, D.L. Bruno, H. Ren, M. Pertile, J.P. Schouten and K.H.A. Choo, Rapid, high throughpout prenatal detection of aneuploidy using a novel quantitative method (MLPA), J. Med. Genet. 40 (2003), 907-912.
24. M. Takata, T. Suzuki, A. Ansai, T. Kimura, F. Shirasaki, N. Hatta and T. Saida, Genome profiling of melanocytic tumors using multiples ligation-dependent probe amplification (MLPA): Its usefulness as an adjunctive diagnostic tool for melanocytic tumors, J. Dermatol. Sci. 40 (2005), 51-57.